These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25928628)

  • 1. Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.
    Gajos G; Konieczynska M; Zalewski J; Undas A
    Cardiovasc Diabetol; 2015 May; 14():44. PubMed ID: 25928628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation.
    Gajos G; Siniarski A; Natorska J; Ząbczyk M; Siudut J; Malinowski KP; Gołębiowska-Wiatrak R; Rostoff P; Undas A
    Cardiovasc Diabetol; 2018 Nov; 17(1):146. PubMed ID: 30466424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
    Gronostaj K; Richter P; Nowak W; Undas A
    Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals.
    Ząbczyk M; Hońdo Ł; Krzek M; Undas A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):50-4. PubMed ID: 23037322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study.
    Bryk AH; Konieczyńska M; Polak M; Plicner D; Bochenek M; Undas A
    Cardiovasc Diabetol; 2021 Feb; 20(1):47. PubMed ID: 33602240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
    Tehrani S; Jörneskog G; Ågren A; Lins PE; Wallén H; Antovic A
    Thromb Haemost; 2015 Feb; 113(2):312-8. PubMed ID: 25318636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of type 2 diabetes on fibrin structure and function.
    Dunn EJ; Ariëns RA; Grant PJ
    Diabetologia; 2005 Jun; 48(6):1198-206. PubMed ID: 15864538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes.
    Konieczyńska M; Bryk AH; Malinowski KP; Draga K; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1671-1678. PubMed ID: 28569923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.
    Undas A; Wiek I; Stêpien E; Zmudka K; Tracz W
    Diabetes Care; 2008 Aug; 31(8):1590-5. PubMed ID: 18487475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Dębski J; Podolak-Dawidziak M; Kuliczkowski K
    Blood Coagul Fibrinolysis; 2015 Sep; 26(6):621-7. PubMed ID: 26083985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered fibrin-clot properties are associated with retinopathy in type 2 diabetes mellitus.
    Walus-Miarka M; Wolkow P; Cyganek K; Mirkiewicz-Sieradzka B; Malecki MT; Undas A
    Diabetes Metab; 2012 Nov; 38(5):462-5. PubMed ID: 22579719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new insight into retinal vein occlusion pathogenesis.
    Karska-Basta I; Kubicka-Trzaska A; Pogrzebielski A; Romanowska-Dixon B
    Klin Oczna; 2013; 115(4):269-74. PubMed ID: 24908915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
    Siudut J; Grela M; Wypasek E; Plens K; Undas A
    J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.